Benefit Street Partners’s Evolent Health EVH Stock Holding History

Benefit Street Partners’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.97M	Buy	+363,165	New	+$1.39M	2.83%	6

Other funds holding EVH

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Allied Private Wealth Boca Raton, Florida $156M AUM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Benefit Street Partners's EVH Position: Q2 2026 in Review

Benefit Street Partners opened a new position in Evolent Health (EVH) in Q2 2026: 363,165 shares worth $1.97M. The stake represents 2.83% of the portfolio and ranks #6 among its holdings.

22 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Benefit Street Partners held 363,165 shares of Evolent Health worth $1.97M as of Q2 2026.
Evolent Health was a new Benefit Street Partners position in Q2 2026.
Evolent Health made up 2.83% of Benefit Street Partners's portfolio in Q2 2026, its #6 holding.
22 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Benefit Street Partners's 13F filing for Q2 2026, filed 21 Jul 2026.